Annual Meeting 2007
Date: 30-31 March 2007
Venue: York
Programme:
Welcome/Introduction
- D Ash, Leeds
New techniques for HDR prostate brachytherapy
- N Zamboglou
HDR dosimetry
- D Baltas, Offenbach
HDR brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer; initial results of a randomised phase III trial
- P Hoskin, Mount Vernon
PSA relapse free survival following prostate brachytherapy — updated five year results
- (J Nobes, Guildford)
(for full presentation, click here)
Dynamic dose/feedback prostate brachytherapy (LDR) in patients with large prostates and/or planned pre-implant to transurethral surgery
- P Acher, Guy's and St Thomas', London
Use of MRI staging imaging in determining patient suitability for prostate brachytherapy
- M Green, Clatterbridge
Dosimetry for prostate seed brachytherapy, a comparison of two techniques
- S Aldridge, Guildford
A comparison of XMR dosimetry and CT based dosimetry for the evaluation of permanent prostate brachytherapy implants
- P Acher, Guy's and St Thomas', London
QA for HDR brachytherapy
- D Baltas, Offenbach
Results of HDR prostate brachytherapy
- N Zamboglou, Offenbach
Effect of a novel prostate implant technique on post implant dosimetry and potency
- J Nobes, Guildford
(for full presentation, click here)
novel prostate implant technique
GEC-ESTRO guidelines for low dose rate seed brachytherapy dosimetry
- P Hoskin, Mount Vernon
Radiation protection issues for seed implants
- P Bownes, Leeds
- T Kehoe, Edinburgh
Post implant dosimetry — impact of local planning technique modifications on rectal doses
- J Nobes, Guildford
(for full presentation, click here)
What, where, when, next?
- D Ash, Leeds